Table 1 Patient characteristics
Total | 20 |
|---|---|
Age (median, range) | 68 (45-87) |
n (%) | |
Sex | |
Male | 13 (65%) |
Female | 7 (35%) |
ECOG performance status at baseline | |
0-1 | 18 (90%) |
2 | 2 (10%) |
Site of primary | |
Gastric | 8 (40%) |
Non-gastric | 12 (60%) |
Previous treatment lines | |
2 | 16 (80%) |
3 | 4 (20%) |
Mutational analysis | |
KIT exon 11 mutation | 12 (60%) |
KIT exon 9 mutation | 1 (5%) |
PDGFR D842V mutation | 1 (5%) |
Not avalilable | 6 (30%) |